Altered neurochemical levels in the rat brain following chronic nicotine treatment

Journal of Chemical Neuroanatomy

Volumn 59-60, Issue , 2014, Pages 29-35

  Falasca, Sara ^a   Ranc, Vaclav ^a   Petruzziello, Filomena ^a   Khani, Abbas ^a   Kretz, Robert ^a   Zhang, Xiaozhe ^a   Rainer, Gregor ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Chronic nicotine; Dorsal striatum; Hypothalamus; Neurochemicals; Prefrontal cortex

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCARNITINE; ACETYLCHOLINE; CARNITINE; CHOLINE; GLUTAMIC ACID; NICOTINE; QUATERNARY AMMONIUM DERIVATIVE; NICOTINIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN STEM; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; DRUG USE; FLUID INTAKE; FOOD INTAKE; FOREBRAIN; HYPOTHALAMUS; INTERNEURON; NEUROCHEMISTRY; NONHUMAN; PARASYMPATHETIC INNERVATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; TREATMENT DURATION; ANIMAL; BIOSYNTHESIS; BRAIN; DRUG EFFECTS; LIQUID CHROMATOGRAPHY; LONG EVANS RAT; MASS SPECTROMETRY; METABOLISM;

ACETYLCHOLINE; ANIMALS; BRAIN; CARNITINE; CHROMATOGRAPHY, LIQUID; GLUTAMIC ACID; MASS SPECTROMETRY; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, LONG-EVANS;

EID: 84905966433     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2014.05.002     Document Type: Article

References (55)

1. Albuquerque E.X., Pereira E.F., Alkondon M., Rogers S.W. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev. 2009, 89:73-120.
2. Barik J., Wonnacott S. Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal. Mol. Pharmacol. 2006, 69:618-628.
3. Benowitz N.L. Nicotine addiction. N. Engl. J. Med. 2010, 362:2295-2303.
4. Changeux J.P. Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nat. Rev. Neurosci. 2010, 11:389-401.
5. Chen H., Hansen M.J., Jones J.E., Vlahos R., Bozinovski S., Anderson G.P., Morris M.J. Regulation of hypothalamic NPY by diet and smoking. Peptides 2007, 28:384-389.
6. Corrigall W.A. Hypocretin mechanisms in nicotine addiction: evidence and speculation. Psychopharmacology (Berl.) 2009, 206:23-37.
7. Couey J.J., Meredith R.M., Spijker S., Poorthuis R.B., Smit A.B., Brussaard A.B., Mansvelder H.D. Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex. Neuron 2007, 54:73-87.
8. Cryer P.E., Haymond M.W., Santiago J.V., Shah S.D. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N. Engl. J. Med. 1976, 295:573-577.
9. Dani J.A., De Biasi M. Cellular mechanisms of nicotine addiction. Pharmacol. Biochem. Behav. 2001, 70:439-446.
10. Dobransky T., Rylett R.J. A model for dynamic regulation of choline acetyltransferase by phosphorylation. J. Neurochem. 2005, 95:305-313.
11. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 2005, 8:1481-1489.
12. Falasca S., Petruzziello F., Kretz R., Rainer G., Zhang X. Analysis of multiple quaternary ammonium compounds in the brain using tandem capillary column separation and high resolution mass spectrometric detection. J. Chromatogr. A 2012, 1241:46-51.
13. Fuchs R.A., Evans K.A., Ledford C.C., Parker M.P., Case J.M., Mehta R.H., See R.E. The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 2005, 30:296-309.
14. Fuxe K., Rosen L., Lippoldt A., Andbjer B., Hasselrot U., Finnman U.B., Agnati L.F. Chronic continuous infusion of nicotine increases the disappearance of choline acetyltransferase immunoreactivity in the cholinergic cell bodies of the medial septal nucleus following a partial unilateral transection of the fimbria fornix. Clin. Investig. 1994, 72:262-268.
15. Grilli M., Parodi M., Raiteri M., Marchi M. Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release. J. Neurochem. 2005, 93:1353-1360.
16. Grilli M., Pittaluga A., Merlo-Pich E., Marchi M. NMDA-mediated modulation of dopamine release is modified in rat prefrontal cortex and nucleus accumbens after chronic nicotine treatment. J. Neurochem. 2009, 108:408-416.
17. Hadjiconstantinou M., Neff N.H. Nicotine and endogenous opioids: neurochemical and pharmacological evidence. Neuropharmacology 2011, 60:1209-1220.
18. Hellerstein M.K., Benowitz N.L., Neese R.A., Schwartz J.M., Hoh R., Jacob P., Hsieh J., Faix D. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J. Clin. Invest. 1994, 93:265-272.
19. Horvath T.L., Andrews Z.B., Diano S. Fuel utilization by hypothalamic neurons: roles for ROS. Trends Endocrinol. Metab. 2009, 20:78-87.
20. Imperato A., Ramacci M.T., Angelucci L. Acetyl-l-carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving rats. Neurosci. Lett. 1989, 107:251-255.
21. Jones L.L., McDonald D.A., Borum P.R. Acylcarnitines: role in brain. Prog. Lipid Res. 2010, 49:61-75.
22. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
23. Lage R., Gonzalez C.R., Dieguez C., Lopez M. Nicotine treatment regulates neuropeptide S system expression in the rat brain. Neurotoxicology 2007, 28:1129-1135.
24. Laviolette S.R., van der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat. Rev. Neurosci. 2004, 5:55-65.
25. Li J., von Pfostl V., Zaldivar D., Zhang X., Logothetis N., Rauch A. Measuring multiple neurochemicals and related metabolites in blood and brain of the rhesus monkey by using dual microdialysis sampling and capillary hydrophilic interaction chromatography-mass spectrometry. Anal. Bioanal. Chem. 2012, 402:2545-2554.
26. Li M.D., Kane J.K., Parker S.L., McAllen K., Matta S.G., Sharp B.M. Nicotine administration enhances NPY expression in the rat hypothalamus. Brain Res. 2000, 867:157-164.
27. Li Z., Vance D.E. Phosphatidylcholine and choline homeostasis. J. Lipid Res. 2008, 49:1187-1194.
28. Marchi M., Zappettini S., Olivero G., Pittaluga A., Grilli M. Chronic nicotine exposure selectively activates a carrier-mediated release of endogenous glutamate and aspartate from rat hippocampal synaptosomes. Neurochem. Int. 2012, 60:622-630.
29. Miller R.R., Heckel C.D., Koss W.J., Montague S.L., Greenman A.L. Ethanol- and nicotine-induced membrane changes in embryonic and neonatal chick brains. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2001, 130:163-178.
30. Mineur Y.S., Abizaid A., Rao Y., Salas R., DiLeone R.J., Gundisch D., Diano S., De Biasi M., Horvath T.L., Gao X.B., Picciotto M.R. Nicotine decreases food intake through activation of POMC neurons. Science 2011, 332:1330-1332.
31. Oddo S., Caccamo A., Green K.N., Liang K., Tran L., Chen Y., Leslie F.M., Ferla La, F.M Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:3046-3051.
32. Ortells M.O., Arias H.R. Neuronal networks of nicotine addiction. Int. J. Biochem. Cell Biol. 2010, 42:1931-1935.
33. Parodi M., Patti L., Grilli M., Raiteri M., Marchi M. Nicotine has a permissive role on the activation of metabotropic glutamate 5 receptors coexisting with nicotinic receptors on rat hippocampal noradrenergic nerve terminals. Neurochem. Int. 2006, 48:138-143.
34. Pettegrew J.W., Panchalingam K., McClure R.J., Levine J. Brain metabolic effects of acute nicotine. Neurochem. Res. 2001, 26:181-185.
35. Picconi B., Barone I., Pisani A., Nicolai R., Benatti P., Bernardi G., Calvani M., Calabresi P. Acetyl-l-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine. Neuropharmacology 2006, 50:917-923.
36. Plaza-Zabala A., Flores A., Maldonado R., Berrendero F. Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal. Biol. Psychiatry 2012, 71:214-223.
37. Quik M., Chen L., Parameswaran N., Xie X., Langston J.W., McCallum S.E. Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates. J. Neurosci. 2006, 26:4681-4689.
38. Rebouche C.J., Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. Annu. Rev. Nutr. 1998, 18:39-61.
39. Ricny J., Tucek S., Novakova J. Acetylcarnitine, carnitine and glucose diminish the effect of muscarinic antagonist quinuclidinyl benzilate on striatal acetylcholine content. Brain Res. 1992, 576:215-219.
40. Risso F., Parodi M., Grilli M., Molfino F., Raiteri M., Marchi M. Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release. Neurochem. Int. 2004, 44:293-301.
41. Rothemund Y., Preuschhof C., Bohner G., Bauknecht H.-C., Klingebiel R., Flor H., Klapp B.F. Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. NeuroImage 2007, 37:410-421.
42. Sanigorski A., Fahey R., Cameron-Smith D., Collier G.R. Nicotine treatment decreases food intake and body weight via a leptin-independent pathway in Psammomys obesus. Diabetes Obes. Metab. 2002, 4:346-350.
43. Shameem M., Patel A.B. Glutamatergic and GABAergic metabolism in mouse brain under chronic nicotine exposure: implications for addiction. PLoS One 2012, 7:e41824.
44. Veeneman M.M.J., Broekhoven M.H., Damsteegt R., Vanderschuren L.J.M.J. Distinct contributions of dopamine in the dorsolateral striatum and nucleus accumbens shell to the reinforcing properties of cocaine. Neuropsychopharmacology 2012, 37:487-498.
45. Wang F., Chen H., Sharp B.M. Neuroadaptive changes in the mesocortical glutamatergic system during chronic nicotine self-administration and after extinction in rats. J. Neurochem. 2008, 106:943-956.
46. Watkins S.S., Koob G.F., Markou A. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob. Res. 2000, 2:19-37.
47. White H.L., Scates P.W. Acetyl-l-carnitine as a precursor of acetylcholine. Neurochem. Res. 1990, 15:597-601.
48. Woolf N.J. A possible role for cholinergic neurons of the basal forebrain and pontomesencephalon in consciousness. Conscious. Cogn. 1997, 6:574-596.
49. Yalachkov Y., Kaiser J., Naumer M.J. Brain regions related to tool use and action knowledge reflect nicotine dependence. J. Neurosci. 2009, 29:4922-4929.
50. Yamamoto D.J., Zahniser N.R. Differences in rat dorsal striatal NMDA and AMPA receptors following acute and repeated cocaine-induced locomotor activation. PLoS One 2012, 7:e37673.
51. Yu Z.J., Wecker L. Chronic nicotine administration differentially affects neurotransmitter release from rat striatal slices. J. Neurochem. 1994, 63:186-194.
52. Zappettini S., Grilli M., Salamone A., Fedele E., Marchi M. Pre-synaptic nicotinic receptors evoke endogenous glutamate and aspartate release from hippocampal synaptosomes by way of distinct coupling mechanisms. Br. J. Pharmacol. 2010, 161:1161-1171.
53. Zhang X., Rauch A., Lee H., Xiao H., Rainer G., Logothetis N.K. Capillary hydrophilic interaction chromatography/mass spectrometry for simultaneous determination of multiple neurotransmitters in primate cerebral cortex. Rapid Commun. Mass Spectrom. 2007, 21:3621-3628.
54. Zhou F.M., Wilson C.J., Dani J.A. Cholinergic interneuron characteristics and nicotinic properties in the striatum. J. Neurobiol. 2002, 53:590-605.
55. Zhu P.J., Chiappinelli V.A. Nicotinic receptors mediate increased GABA release in brain through a tetrodotoxin-insensitive mechanism during prolonged exposure to nicotine. Neuroscience 2002, 115:137-144.